Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-06
2005-09-06
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S177000, C546S178000, C546S180000, C514S314000, C514S311000
Reexamination Certificate
active
06939970
ABSTRACT:
The present invention comprises monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structureand as herein defined by powder X-ray diffraction, processes for preparing monohydrated form C from amorphorous (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid or form A of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, pharmaceutical compositions comprising monohydrated form C, pharmaceutical compositions comprising monohydrated form C and form A or form B of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, pharmaceutical compositions comprising monohydrated form C, form A and form B, methods for treating bacterial infection with monohydrated form C, methods for treating bacterial infection with monohydrated form C and form A or form B, methods for treating bacterial infection with monohydrated form C, form A and form B, and a process for the preparation of form A from monohydrated form C.
REFERENCES:
patent: 6403610 (2002-06-01), Malleron et al.
patent: 6602884 (2003-08-01), Bacque et al.
patent: 2004/0147751 (2004-07-01), Bourget
Billot Pascal
Bourget Jacques
Janocha Bernd
Lafont Sylvaine
Neves Carole
Aventis Pharma S. A.
Gupta Balaram
Seaman D. Margaret
LandOfFree
Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3430024